Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Matteo Salsa

1PUBLICATIONS

12CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Sep 18, 2023

Novel Thienoduocarmycin-Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies.

Barbara Valsasina, Paolo Orsini, Michele Caruso

Pageof 1

Frequent Collaborators

1 joint publications

Barbara Valsasina

1 joint publications

Paolo Orsini

1 joint publications

Michele Caruso

1 joint publications

Clara Albanese

1 joint publications

Antonella Ciavolella

1 joint publications

Ulisse Cucchi

1 joint publications

Ivan Fraietta

1 joint publications

Nicola Melillo

1 joint publications

Francesco Fiorentini

1 joint publications

Simona Rizzi

Frequent Collaborators

1 joint publications

Barbara Valsasina

1 joint publications

Paolo Orsini

1 joint publications

Michele Caruso

1 joint publications

Clara Albanese

Top Related Videos

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

See more related videos

Top Related Videos

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

See more related videos